Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication

Fig. 1

E7 SLP adjuvanted with CpG promotes antigen specific CD8 T cells expansion. Mice (n = 5) were immunized s.c. on day 0 and 21 with 5 μg E7 SLP adjuvanted with the TLR agonists and indicated doses. Splenocytes were isolated on day 28 and stained with E7-specific dextramers for FACS analysis. a Representative dot plots of E7 antigen specific dextramer staining of CD8 T cells. b The percentage of E7-specific dextramer+ CD8 T cells is presented for each vaccine condition. Two-sided hypothesis test for comparisons using one-way ANOVA model **, p < 0.01

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us